Tag: Eli Lilly and Company
Innovent Biologics, Sanofi to expedite development of cancer drugs in China
Chinese biopharma company Innovent Biologics and French pharma giant Sanofi have entered into a partnership that aims to bring innovative drugs to patients in China ... Read More
Lilly to invest $2.1bn in two new pharma manufacturing plants in Indiana
Eli Lilly and Company (Lilly) said that it will invest $2.1 billion to build two new pharma manufacturing plants in Indiana, which will be located ... Read More
FDA rejects Lilly’s sintilimab as first line treatment of NSCLC
The US Food and Drug Administration (FDA) has rejected the biologics license application (BLA) of Eli Lilly and Company (Lilly)’s sintilimab injection in nonsquamous non-small ... Read More
Lilly to open $700m Lilly Institute for Genetic Medicine in Boston
Eli Lilly and Company (Lilly) has revealed plans to open a new research facility for genetic medicine dubbed as Lilly Institute for Genetic Medicine in ... Read More
Lilly, US govt sign deal for 600,000 doses of Covid-19 drug bebtelovimab
Eli Lilly and Company (Lilly) has signed a deal worth at least $720 million with the US government to deliver up to 600,000 doses of ... Read More
Lilly gets FDA EUA for bebtelovimab in mild-to-moderate Covid-19
Eli Lilly and Company (Lilly) has secured Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for bebtelovimab for the treatment of ... Read More
Arkuda Therapeutics gets $64m booster to advance neurodegenerative treatment
Arkuda Therapeutics, a US-based biotechnology company, has raised $64 million in Series B financing. The new funding will help Arkuda Therapeutics boost the production of ... Read More
Lilly to build $1bn manufacturing plant in Concord, North Carolina
Eli Lilly and Company (Lilly) said that it will invest more than $1 billion to build a new manufacturing plant in Concord, North Carolina. The ... Read More
Cipla signs licensing deal with Lilly to sell two diabetes drugs in India
Cipla has signed a licensing deal with the Indian subsidiary of US pharma giant Eli Lilly and Company (Lilly) pertaining to the latter’s diabetes treatments ... Read More
Lilly takes full ownership of biotech company Protomer Technologies
Eli Lilly and Company (Lilly) has taken full ownership of California-based biotech company Protomer Technologies in a deal that is potentially worth more than $1 ... Read More